Attitudes Toward COVID-19 Vaccination Among Pediatric Acute Lymphoblastic Leukemia Patients and Their Caregivers.

IF 2.4 3区医学 Q2 HEMATOLOGY

Pediatric Blood & Cancer Pub Date : 2025-03-28 DOI:10.1002/pbc.31696

Janna R Shapiro, Gilla K Shapiro, Sumit Gupta, Sarah Alexander, Michelle Science, Tania H Watts, Shelly Bolotin

引用次数: 0

Abstract

The COVID-19 vaccine is indicated for children with acute lymphoblastic leukemia (ALL), yet patients and caregivers may have unique questions and concerns about vaccination. We surveyed children with ALL or their caregivers (N = 44) to understand factors contributing to the decision to vaccinate and identify cues to vaccination tailored to this population. For caregivers of unvaccinated ALL patients, lack of knowledge about the COVID-19 vaccine and concerns about vaccine safety and efficacy were the most reported barriers to vaccination. A recommendation from a hematologist/oncologist and vaccine safety and efficacy data in children with ALL were the most cited cues to vaccination.

查看原文本刊更多论文

COVID-19 疫苗适用于急性淋巴细胞白血病 (ALL) 患儿，但患者和护理人员可能会对接种疫苗有独特的疑问和顾虑。我们对患有急性淋巴细胞白血病的儿童或其看护者（N = 44）进行了调查，以了解促使他们决定接种疫苗的因素，并找出适合这一人群的疫苗接种提示。对于未接种疫苗的 ALL 患者的看护者来说，缺乏对 COVID-19 疫苗的了解以及对疫苗安全性和有效性的担忧是他们报告最多的接种障碍。血液/肿瘤专家的建议以及ALL儿童接种疫苗的安全性和有效性数据是被提及最多的疫苗接种提示。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Pediatric Blood & Cancer 医学-小儿科

CiteScore

4.90

自引率

9.40%

发文量

546

审稿时长

1.5 months

期刊介绍： Pediatric Blood & Cancer publishes the highest quality manuscripts describing basic and clinical investigations of blood disorders and malignant diseases of childhood including diagnosis, treatment, epidemiology, etiology, biology, and molecular and clinical genetics of these diseases as they affect children, adolescents, and young adults. Pediatric Blood & Cancer will also include studies on such treatment options as hematopoietic stem cell transplantation, immunology, and gene therapy.